Condition: Pulmonary Arterial Hypertension · Sponsor: Merck Sharp & Dohme LLC
The primary objectives of the study are to evaluate the safety and tolerability, and pharmacokinetics (PK) of sotatercept over 24 weeks of treatment in children ≥1 to \<18 years of age with PAH World Health Organization (WHO) Group 1 on standard of care (SoC). There is no formal hypothesis.
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| The Regents of the University of California - Los Angeles (UCLA Pediatrics) ( Site 1606) | Los Angeles, California, United States | Recruiting |
| Stanford University School of Medicine ( Site 1603) | Palo Alto, California, United States | Recruiting |
| UCSF Benioff Children's Hospital San Francisco ( Site 1611) | San Francisco, California, United States | Recruiting |
| Children's Hospital Colorado ( Site 1609) | Aurora, Colorado, United States | Recruiting |
| Children's National Medical Center ( Site 1600) | Washington D.C., District of Columbia, United States | Recruiting |
| Cincinnati Children's Hospital Medical Center ( Site 1602) | Cincinnati, Ohio, United States | Recruiting |
| Children's Hospital of Philadelphia (CHOP) ( Site 1608) | Philadelphia, Pennsylvania, United States | Recruiting |
| Monroe Carell Jr. Children's Hospital ( Site 1601) | Nashville, Tennessee, United States | Completed |
| Seattle Children's Hospital ( Site 1605) | Seattle, Washington, United States | Recruiting |
| Children's Wisconsin ( Site 1610) | Milwaukee, Wisconsin, United States | Recruiting |
| The Children's Hospital at Westmead ( Site 0001) | Westmead, New South Wales, Australia | Recruiting |
| Clinica Somer-Unidad de Investigacion y Docencia ( Site 0205) | Rionegro, Antioquia, Colombia | Recruiting |
+ 23 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05587712